The Antiandrogens Market is witnessing a significant evolution due to the rising prevalence of prostate cancer and other hormone-related disorders. Recent studies indicate that both established and emerging therapies are shaping the market landscape. Key drivers include increasing awareness about hormone therapy and technological advancements in drug delivery systems. The US remains a major...